Slovene pharmaceutical company Lek d.d. has successfully defended its patent EP 1 095 037, which covers Lek’s synthesis of omeprazole before the Board of ...
Slovene pharmaceutical company Lek d.d. has successfully defended its patent EP 1 095 037, which covers Lek’s synthesis of omeprazole before the Board of ...
Today, the Slovene Chamber of Commerce, bestowed the award of Innovator of the Year 2002 to a group composed of Dr. Viktor Menart and ...
Ljubljana, 25 November 2003 – After the settlement signed in July of 2003 between GlaxoSmithKline PLC (GSK) and Novartis, including Lek d.d. ...
The pharmaceutical company Lek submitted adjusted prices for its leading products to the Agency for Medicinal Products of the Republic of Slovenia (the Agency). ...
Ljubljana, 25 September 2003 – After years of fruitful cooperation, the co-founders and co-shareholders of Bayer Pharma d.o.o. decided on ownership change in Joint ...
On Monday, 1 September 2003, the change of the company name and company headquarters of Lodz-based Argon SA was entered into the Court Register. ...
On Monday, 25 August 2003, the President of the Polish Government, Mr Leszek Miller, visited Lek’s new plant, a Manufacturing and Logistics Centre in ...
Novartis has taken a decision on Lek’s launching a generic omeprazole in the US market this week.
We would like to inform you that the 19th General Meeting of Lek d.d. was held on Thursday, 31 July 2003, at the headquarters ...
At the invitation of the company Lek d.d., Mr. Krzystof Makowski, Duke of the Polish Lodz region, came to visit Slovenia. During the visit, ...
After the company Novartis had entered into the ownership structure of Lek d.d., the 2nd meeting of Lek Supervisory Board was held on Friday, ...
On the basis of the Statute of the joint-stock company Lek, we hereby convene the 19th General Meeting of Lek d.d. to be held ...
Following the cornerstone celebration at Lek’s Pharmaceutical Production and Logistics Centre in Stryków near Łódź in September last year, attended by Presidents Aleksander Kwaśniewski ...
Based on one reported case from a pharmacy, received on Friday, April 11, Lek Pharmaceuticals, d.d. is informing the public that there was a ...
A resolution on the ban on the distribution and use of the drug Dermo spray N, dermal spray produced by Lek d.d., was issued ...
On Thursday, 27 March 2003, the newly appointed Supervisory Board of Lek Pharmaceuticals d.d. held its first meeting. The composition of the Supervisory Board ...
The year 2002 was a major turning point for Lek – the takeover by the Swiss firm Servipharm AG, which is 100% owned by ...
Lek Pharmaceuticals d.d., Verovškova 57, Ljubljana, hereby announces that
A Slovenian pharmaceutical company, Lek Pharmaceuticals d.d., was granted by the US Food and Drug Administration (FDA) a final approval for the marketing ...
Lek Pharmaceuticals d.d. hereby announces that they have issued, in accordance with Article 66 of the Act on Medicinal Products and Medical Devices, a ...
Lek Pharmaceuticals d.d., Verovškova 57, Ljubljana, hereby announces that at the 18th General Meeting of the joint-stock company, held on 20 January 2003, Lek ...
Ljubljana, January 6, 2003 – Lek d.d, a Slovene pharmaceutical company, has entered the world’s largest pharmaceuticals market with its leading product, co-amoxiclav. By ...